Headlines
- Regional Health Properties (RHE) has received a notice from NYSE American regarding delisting.
- The company has been given the option to appeal this decision, with the process set to continue.
- Despite this notice, RHE intends to keep its securities trading on NYSE American during the appeal period.
Regional Health Properties (NYSE:RHE) recently announced it had received a delisting notice from NYSE American on November 11, 2024. The notification indicated that NYSE Regulation had started proceedings to remove the company’s common stock and Series A Redeemable Preferred Shares from the exchange. The delisting determination was based on the company’s failure to regain compliance with the NYSE American Company Guide’s listing standards, specifically Sections 1003(a)(i) and (ii), by the end of the allotted compliance period.
The company was unable to demonstrate that it had met these requirements by the expiration of the 18-month compliance plan on November 10, 2024. Under these circumstances, NYSE Regulation determined that RHE no longer met the necessary qualifications for listing.
However, Regional Health Properties has the right to request a review of the decision. This review will be conducted by the Listings Qualifications Panel, part of the Committee for Review of the NYSE American Board of Directors. RHE has until November 18, 2024, to file an appeal, and the company has expressed its intent to contest the delisting decision.
As part of the appeal process, RHE’s securities will continue trading on NYSE American while the matter is under review. The company remains committed to resolving the issue and maintaining its listing status on the exchange during this period.